Predicting the unpredictable mortality outcome of valve-in-valve interventions.
Surgical aortic valve replacement (AVR) risk scores overestimate valve-in-valve (ViV) transcatheter AVR (TAVR) mortality, with moderate discrimination Due to low prevalence of 30-day mortality, positive predictive value is low Specific risk score examining multiple outcomes for TAVR and ViV patients are needed.